• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804250-18
Device Problems Material Rupture (1546); Difficult or Delayed Activation (2577); Patient-Device Incompatibility (2682)
Patient Problems Cardiac Arrest (1762); Non specific EKG/ECG Changes (1817); Low Blood Pressure/ Hypotension (1914)
Event Date 09/08/2022
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a mid circumflex artery that was 90% stenosed.The lesion was pre-dilated with a 2.5x15mm nc trek at 2 inflations without issue.Then a 2.5x18mm xience skypoint stent was advanced to the lesion without issue.Deployment was initiated and the stent partially deployed, when it was noted that the stent-balloon could not be pressurized past 2 atmospheres and leakage was noted coming from a pinhole on the balloon.The stent implant had partially deployed at the lesion (not well apposed to the vessel wall), so it was decided to remove the delivery system.The patients pressure immediately dropped and ekg changes were noted.The patient became unresponsive for 30 seconds.Medication was administered and the patients vitals stabilized and returned to normal.Then a 1.5x8mm and a 2.5mm balloons were used to fully implant the xience implant successfully.The patient is fine.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material rupture was confirmed.The reported wall apposition could not be replicated in a testing environment as they are related to operational context of the procedure.The reported delayed/difficult activation could not be confirmed as the stent was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effect of hypotension is listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported material rupture; however, factors that may contribute to material ruptures include, but are not limited to, material damage, interactions with other devices or interaction with lesion calcification and tortuosity.The reported difficult activation of the stent, wall apposition and subsequent treatment appear to be related to operational context as it is likely the ruptured balloon and was unable to fully expand the stent to the vessel wall.The reported patient effects are known inherent risks of the procedure.Additionally, there was no damage or leak noted to the stent delivery system (sds) during the inspection prior to use or during preparation of the device, which suggests a product quality issue did not contribute to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15499328
MDR Text Key300725775
Report Number2024168-2022-10076
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233081
UDI-Public08717648233081
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1804250-18
Device Catalogue Number1804250-18
Device Lot Number2051341
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/17/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age62 YR
Patient SexFemale
Patient Weight81 KG
-
-